Gilead Sciences
GILD
#97
Rank
$173.68 B
Marketcap
$139.93
Share price
0.40%
Change (1 day)
25.77%
Change (1 year)

Gilead Sciences (GILD) - Total debt

Total debt on the balance sheet as of December 2025 : $24.93 Billion USD

According to Gilead Sciences's latest financial reports the company's total debt is $24.93 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Gilead Sciences - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-12-31$24.93 B-6.65%
2024-12-31$26.71 B6.9%
2023-12-31$24.98 B-0.96%
2022-12-31$25.23 B-5.49%
2021-12-31$26.69 B-14.99%
2020-12-31$31.40 B27.69%
2019-12-31$24.59 B-9.99%
2018-12-31$27.32 B-18.54%
2017-12-31$33.54 B27.31%
2016-12-31$26.34 B19.46%
2015-12-31$22.05 B77.81%
2014-12-31$12.40 B86.92%
2013-12-31$6.63 B-19.31%
2012-12-31$8.22 B8.11%
2011-12-31$7.60 B118.29%
2010-12-31$3.48 B179.15%
2009-12-31$1.24 B7.6%
2008-12-31$1.16 B-11.56%
2007-12-31$1.31 B-7%
2006-12-31$1.41 B368.86%
2005-12-31$0.30 B72395.42%
2004-12-31$0.41 M-99.88%
2003-12-31$0.34 B-41.98%
2002-12-31$0.59 B136.41%
2001-12-31$0.25 B-1.33%
2000-12-31$0.25 B190.16%
1999-12-31$87.97 M-13.32%
1998-12-31$0.10 B3071.88%
1997-12-31$3.2 M-50.77%
1996-12-31$6.5 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
$47.93 B 92.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$63.96 B 156.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$67.49 B 170.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$42.50 B 70.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$54.60 B 118.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$6.57 B-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$2.55 B-89.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$2.03 B-91.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$49.33 B 97.86%๐Ÿ‡บ๐Ÿ‡ธ USA